Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
About Us
BoD
Ragnar Linder - Director
-
Dr Ragnar Linder was the Managing Director of Amgen in Scandinavia from 2001 to 2004. Prior to that, he was with the Sanofi-Aventis Group from 1980 to 2001 in senior positions in Europe and the USA. His final position was Director New CNS products in the Global Marketing and Medical Group of Aventis. He is now the CEO of Pygargus AB, a CRO acting in the Scandinavian region. He brings to Newron's Board sales and marketing experience of more than 25 years in international pharmaceutical industry.